You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it.
NO
YES

HIGHLIGHTS

EVENTS

Leading medical-scientific event on Hemophilia held in Trieste, Italy

Kedrion-organized congress put replacement therapy, personalization and access to care in the spotlight

read more 

EVENTS

Kedrion scientific symposium at the 2019 PNS Conference in Genoa, Italy

A chance for world Key Opinion Leaders to debate possible new therapies for the treatment of CIPN

read more 

PLASMA & BIOTHERAPIES

First patient enrolled and treated in Kedrion’s CARES10 clinical study

Phase 3 study to assess efficacy, safety and pharmacokinetics of a 10% IVIg in the treatment of adult PID patients

read more 

  1. EVENTS - 17-07-2019

    Leading medical-scientific event on Hemophilia held in Trieste, Italy

    Kedrion-organized congress put replacement therapy, personalization and access to care in the spotlight

    read more 

  2. EVENTS - 05-07-2019

    Kedrion scientific symposium at the 2019 PNS Conference in Genoa, Italy

    A chance for world Key Opinion Leaders to debate possible new therapies for the treatment of CIPN

    read more 

  3. PLASMA & BIOTHERAPIES - 20-06-2019

    First patient enrolled and treated in Kedrion’s CARES10 clinical study

    Phase 3 study to assess efficacy, safety and pharmacokinetics of a 10% IVIg in the treatment of adult PID patients

    read more 

  4. EVENTS - 20-06-2019

    June 27 and 28 in Trieste (Italy), a two-day event dedicated to hemophilia

    Replacement therapy, personalization and access to treatment are the main themes of the congress organized by Kedrion

    read more 

Pages

For more information please contact: pressoffice@kedrion.com